|
Akers Biosciences, Inc. develops, manufactures, and supplies point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician. The Company’s product offerings focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including diagnostic rapid manual point-of-care tests for the detection of allergic reactions to Heparin and for on- and off-the-job alcohol safety initiatives. The Company's primary focus is on the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.
Number of employees : 12 people.
|
|
| 2018 | 2019 | Delta | USD (in Million) | % | USD (in Million) | % | Particle ImmunoFiltration Assay | 1.42 | 85.4% | 1.33 | 84.2% | -6.65% | MicroParticle Catalyzed Biosensor | 0.124 | 7.4% | 0.126 | 8% | +1.78% | Rapid Enzymatic Assay | 0.069 | 4.1% | 0.085 | 5.4% | +23.64% | Other | 0.051 | 3% | 0.038 | 2.4% | -24.52% |
|
|
| 2018 | 2019 | Delta | USD (in Million) | % | USD (in Million) | % | United States | 1.58 | 94.7% | 1.56 | 98.9% | -1.09% | Rest of World | 0.089 | 5.3% | 0.018 | 1.1% | -80.29% |
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
8,859,868 |
7,438,205 |
84.0% |
0 |
0.0% |
84.0% |
|
|
Name | Equities | % | Iroquois Capital Management LLC | 1,040,540 |
11.7% | Intracoastal Capital LLC | 729,729 |
8.24% | Sabby Capital LLC | 299,913 |
3.39% | Hudson Bay Capital Management LP | 240,305 |
2.71% | Armistice Capital LLC | 190,714 |
2.15% | Anson Funds Management LP | 109,500 |
1.24% | Susquehanna Investment Group LLC | 44,583 |
0.50% | Renaissance Technologies LLC | 41,708 |
0.47% | Candriam Belgium SA | 36,146 |
0.41% | The Vanguard Group, Inc. | 35,980 |
0.41% |
|
Company contact information |
|
| |
|
Sector Medical Equipment, Supplies & Distribution - NEC
Connections : Akers Biosciences, Inc.
|